K2M received FDA 510(k) clearances to market CASCADIA™ Cervical and CASCADIA AN Lordotic Oblique Interbody Systems, featuring Lamellar 3D-printed Titanium Technology™.
All CASCADIA interbody systems are cleared for use with autologous and allogenic bone graft to treat degenerative disc disease and degenerative scoliosis.
K2M also received clearance to market additional offerings of CASCADIA TL and CASCADIA Cervical Interbody Systems. The complete CASCADIA line includes the CASCADIA Lateral and AN Interbody Systems, both of which received FDA 510(k) clearance within the past year.
K2M received FDA 510(k) clearances to market CASCADIA™ Cervical and CASCADIA AN Lordotic Oblique Interbody Systems, featuring Lamellar 3D-printed Titanium Technology™.
All CASCADIA interbody systems are cleared for use with autologous and allogenic bone graft to treat degenerative disc disease and degenerative scoliosis.
K2M also received...
K2M received FDA 510(k) clearances to market CASCADIA™ Cervical and CASCADIA AN Lordotic Oblique Interbody Systems, featuring Lamellar 3D-printed Titanium Technology™.
All CASCADIA interbody systems are cleared for use with autologous and allogenic bone graft to treat degenerative disc disease and degenerative scoliosis.
K2M also received clearance to market additional offerings of CASCADIA TL and CASCADIA Cervical Interbody Systems. The complete CASCADIA line includes the CASCADIA Lateral and AN Interbody Systems, both of which received FDA 510(k) clearance within the past year.
Copy to clipboard 
